Standard BioTools
LAB
LAB
121 hedge funds and large institutions have $220M invested in Standard BioTools in 2021 Q4 according to their latest regulatory filings, with 22 funds opening new positions, 33 increasing their positions, 44 reducing their positions, and 19 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less ownership
Funds ownership: →
25% less repeat investments, than reductions
Existing positions increased: 33 | Existing positions reduced: 44
43% less capital invested
Capital invested by funds: $387M → $220M (-$166M)
100% less funds holding in top 10
Funds holding in top 10: 2 → 0 (-2)
Holders
121
Holding in Top 10
–
Calls
$1.92M
Puts
$987K
Top Buyers
| 1 | +$1.49M | |
| 2 | +$1.1M | |
| 3 | +$904K | |
| 4 |
NIM
Needham Investment Management
New York
|
+$882K |
| 5 |
HighTower Advisors
Chicago,
Illinois
|
+$751K |
Top Sellers
| 1 | -$8.85M | |
| 2 | -$3.06M | |
| 3 | -$2.64M | |
| 4 |
Two Sigma Investments
New York
|
-$1.13M |
| 5 |
Principal Financial Group
Des Moines,
Iowa
|
-$745K |